Atlas Trials

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

Clinical trial NCT07038551 · COMPLETED

Trial details

NCT number
NCT07038551
Sponsor
International University of Health and Welfare
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Opioid-Induced Nausea and Vomitting(OINV)
Start date
2025-06-20
Primary completion
2026-02-13
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.